12 Health Care Stocks Moving In Tuesday's After-Market Session

Benzinga·05/13/2025 21:06:18

Listen to the news

Gainers

Innovative Eyewear (NASDAQ:LUCY) shares increased by 57.2% to $2.94 during Tuesday's after-market session. The market value of their outstanding shares is at $8.9 million.
Apyx Medical (NASDAQ:APYX) stock rose 42.98% to $1.58. The market value of their outstanding shares is at $59.7 million. The company's, Q1 earnings came out 3 days ago.
Xilio Therapeutics (NASDAQ:XLO) stock moved upwards by 40.9% to $1.03. The company's market cap stands at $53.3 million. As per the press release, Q1 earnings came out 3 days ago.
Omeros (NASDAQ:OMER) stock increased by 16.2% to $4.41. The company's market cap stands at $255.5 million.
Hims & Hers Health (NYSE:HIMS) shares moved upwards by 15.92% to $64.0. The market value of their outstanding shares is at $14.3 billion.
Agape ATP (NASDAQ:ATPC) stock increased by 15.15% to $1.9. The company's market cap stands at $95.0 million.

Losers

Polyrizon (NASDAQ:PLRZ) stock declined by 95.5% to $0.02 during Tuesday's after-market session.
Accelerate Diagnostics (NASDAQ:AXDX) shares fell 44.08% to $0.07. The company's market cap stands at $1.8 million.
Regencell Bioscience (NASDAQ:RGC) shares decreased by 36.9% to $296.59. The company's market cap stands at $3.8 billion.
Halozyme Therapeutics (NASDAQ:HALO) stock fell 24.91% to $50.0. The market value of their outstanding shares is at $6.1 billion.
Kindly MD (NASDAQ:KDLY) stock declined by 23.96% to $10.41. The market value of their outstanding shares is at $62.2 million. As per the press release, Q1 earnings came out 3 days ago.
Vivani Medical (NASDAQ:VANI) shares decreased by 20.39% to $0.82. The company's market cap stands at $54.6 million. The company's, Q1 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English